Literature DB >> 22503948

Unexplained infertility: an update and review of practice.

Arpita Ray1, Amit Shah, Anil Gudi, Roy Homburg.   

Abstract

Of the couples unable to conceive without any identifiable cause, 30% are defined as having unexplained infertility. Management depends on duration of infertility and age of female partner. This review describes and comments on the definition and evidence for the management of unexplained infertility. A literature search was conducted in EMBASE, Medline, Ovid and Cochrane Database of Systematic reviews using the terms 'infertility', 'unexplained infertility', 'idiopathic infertility', 'definition of infertility', 'treatment options', 'intrauterine insemination', 'ovulation induction', 'Fallopian tube sperm', 'GIFT' and 'IVF'. There is no uniform definition for unexplained infertility. This varies in the literature depending on the duration of infertility and the age of the female partner. The treatment of unexplained infertility is empirical and many different regimens have been used. Among these are expectant management, ovulation stimulation with clomiphene citrate, gonadotrophins and aromatase inhibitors, Fallopian tube sperm perfusion, tubal flushing, intrauterine insemination, gamete intra-Fallopian transfer and IVF. The standard protocol is to progress from low-technology to high-technology treatment options. On the best available evidence, an algorithm for management is suggested. There is a definite need for multicentre randomized controlled trials to identify the best treatment option in unexplained infertility using a standard definition.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22503948     DOI: 10.1016/j.rbmo.2012.02.021

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  52 in total

Review 1.  Gamete-mediated mate choice: towards a more inclusive view of sexual selection.

Authors:  Jukka Kekäläinen; Jonathan P Evans
Journal:  Proc Biol Sci       Date:  2018-07-18       Impact factor: 5.349

2.  NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study.

Authors:  Maria Antonietta Castiglione Morelli; Assunta Iuliano; Sergio Crescenzo Antonio Schettini; Donatina Petruzzi; Angela Ferri; Paola Colucci; Licia Viggiani; Flavia Cuviello; Angela Ostuni
Journal:  Metabolomics       Date:  2019-01-29       Impact factor: 4.290

3.  Comparing reactive oxygen species and DNA fragmentation in semen samples of unexplained infertile and healthy fertile men.

Authors:  Zahra Zandieh; Akram Vatannejad; Mahmood Doosti; Sara Zabihzadeh; Mahnaz Haddadi; Leila Bajelan; Batool Rashidi; Saeid Amanpour
Journal:  Ir J Med Sci       Date:  2017-11-15       Impact factor: 1.568

4.  Special characteristics, reproductive, and clinical profile of women with unexplained infertility versus other causes of infertility: a comparative study.

Authors:  Charalampos Siristatidis; Abraham Pouliakis; Theodoros N Sergentanis
Journal:  J Assist Reprod Genet       Date:  2020-06-05       Impact factor: 3.412

5.  Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility.

Authors:  Abdelmoneim Younis; Kristina Hawkins; Halleh Mahini; William Butler; Mahdi Garelnabi
Journal:  J Assist Reprod Genet       Date:  2014-09-04       Impact factor: 3.412

6.  Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction.

Authors:  Violanda Grigorescu; Yujia Zhang; Dmitry M Kissin; Erin Sauber-Schatz; Mithi Sunderam; Russell S Kirby; Hafsatou Diop; Patricia McKane; Denise J Jamieson
Journal:  Fertil Steril       Date:  2014-01-30       Impact factor: 7.329

Review 7.  Oral Health Status and Fertility Treatment Including IVF.

Authors:  Sunali Sundeep Khanna; Prita A Dhaimade; Shalini Malhotra
Journal:  J Obstet Gynaecol India       Date:  2017-06-20

8.  Tamoxifen is a potent antioxidant modulator for sperm quality in patients with idiopathic oligoasthenospermia.

Authors:  Li Guo; Jun Jing; Yu-Ming Feng; Bing Yao
Journal:  Int Urol Nephrol       Date:  2015-07-28       Impact factor: 2.370

Review 9.  Targeting testis-specific proteins to inhibit spermatogenesis: lesson from endocrine disrupting chemicals.

Authors:  H T Wan; Dolores D Mruk; Chris K C Wong; C Yan Cheng
Journal:  Expert Opin Ther Targets       Date:  2013-04-22       Impact factor: 6.902

10.  A Mouse Model for Dietary Xenosialitis: ANTIBODIES TO XENOGLYCAN CAN REDUCE FERTILITY.

Authors:  Fang Ma; Liwen Deng; Patrick Secrest; Linda Shi; June Zhao; Pascal Gagneux
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.